Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dr Reddys Laboratories (RDY) Revenue (2016 - 2025)

Historic Revenue for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $979.9 million.

  • Dr Reddys Laboratories' Revenue fell 101.31% to $979.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 billion, marking a year-over-year increase of 543.66%. This contributed to the annual value of $3.8 billion for FY2025, which is 1376.12% up from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Revenue of $979.9 million as of Q4 2025, which was down 101.31% from -$75.1 million recorded in Q3 2025.
  • Dr Reddys Laboratories' Revenue's 5-year high stood at $990.0 million during Q4 2024, with a 5-year trough of -$75.1 million in Q3 2025.
  • Over the past 5 years, Dr Reddys Laboratories' median Revenue value was $801.0 million (recorded in 2022), while the average stood at $767.4 million.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 2652.11% in 2023, then crashed by 10784.18% in 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Revenue (Quarter) stood at $688.0 million in 2021, then increased by 11.48% to $767.0 million in 2022, then grew by 12.97% to $866.5 million in 2023, then rose by 14.25% to $990.0 million in 2024, then decreased by 1.01% to $979.9 million in 2025.
  • Its Revenue stands at $979.9 million for Q4 2025, versus -$75.1 million for Q3 2025 and $982.3 million for Q1 2025.